EW · Edwards Lifesciences Corp

$89.95 -0.83 (-0.91%) At close · Aug 27

Market Cap

$51.85B

576.40M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-04	2026-06-30
8-K	2026-07-23	—
8-K	2026-05-08	2026-05-07
10-Q	2026-05-06	2026-03-31
8-K	2026-05-04	2026-05-02
8-K	2026-04-23	—
DEF 14A	2026-03-26	2026-05-07
Investor Event Transcript	2026-03-10	2026-03-31
10-K	2026-02-25	2025-12-31
8-K	2026-02-10	—
8-K	2026-01-12	2026-01-09
10-Q	2025-11-05	2025-09-30
8-K	2025-10-30	—
8-K	2025-10-30	—
8-K	2025-08-19	—
8-K	2025-08-06	—
10-Q	2025-08-06	2025-06-30
8-K	2025-07-25	2025-07-21
8-K	2025-07-24	—
8-K	2025-05-08	—
10-Q	2025-05-06	2025-03-31
8-K	2025-04-23	—
DEF 14A	2025-03-26	2024-12-31
10-K	2025-02-28	2024-12-31
8-K	2025-02-11	—
10-Q	2024-11-06	2024-09-30
8-K	2024-10-24	—
8-K	2024-09-03	—
10-Q	2024-07-31	2024-06-30
8-K	2024-07-24	—
8-K	2024-07-15	—
8-K	2024-07-10	—
8-K	2024-06-17	2024-06-14
8-K	2024-06-03	—
8-K	2024-05-08	2024-05-07
10-Q	2024-04-29	2024-03-31
8-K	2024-04-25	—
DEF 14A	2024-03-26	2023-12-31
8-K	2024-03-26	—
10-K	2024-02-12	2023-12-31
8-K	2024-02-06	—
8-K	2023-12-07	—
10-Q	2023-10-27	2023-09-30
8-K	2023-10-25	—
10-Q	2023-07-28	2023-06-30
8-K	2023-07-26	—
8-K	2023-05-15	2023-05-11
10-Q	2023-04-28	2023-03-31
8-K	2023-04-26	—
DEF 14A	2023-03-28	0001-01-01

Showing 1–50 of 89 filings

Key facts CIK 1099800 CUSIP 28176E108 13F (30d) 878 filings 876 filers Visit website Investor relations